Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials.

Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials. Clin Cancer Res. 2017 Jan 01; 23(1):13-20.

View in: PubMed

subject areas

Algorithms
Cell- and Tissue-Based Therapy
Clinical Trials, Phase I as Topic
Computer Simulation
Humans
Immunotherapy, Adoptive
Models, Statistical
Neoplasms
Probability
Research Design
Treatment Outcome

authors with profiles

Yuan Ji